{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:17:49Z","timestamp":1762543069327,"version":"3.37.3"},"reference-count":71,"publisher":"Bentham Science Publishers Ltd.","issue":"7","funder":[{"DOI":"10.13039\/501100001794","name":"University of Queensland","doi-asserted-by":"publisher","award":["606431"],"award-info":[{"award-number":["606431"]}],"id":[{"id":"10.13039\/501100001794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council.","doi-asserted-by":"publisher","award":["APP1026488"],"award-info":[{"award-number":["APP1026488"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDD"],"published-print":{"date-parts":[[2019,10,3]]},"abstract":"<jats:sec><jats:title\/><jats:p>Despite advances in the development of new vaccines, there are still some diseases with no vaccine solutions. Therefore, further efforts are required to more comprehensively discern the different antigenic components of these microorganisms on a molecular level. This review summarizes advancement in the development of new carbohydrate-based vaccines. Following traditional vaccine counterparts, the carbohydrate-based vaccines introduced a new approach in fighting infectious diseases. Carbohydrates have played various roles in the development of carbohydrate-based vaccines, which are described in this review, including carbohydrates acting as antigens, carriers or targeting moieties. Carbohydrate-based vaccines against infectious diseases, such as group A streptococcus, meningococcal meningitis and human immunodeficiency virus, are also discussed. A number of carbohydrate- based vaccines, such as Pneumovax 23, Menveo and Pentacel, have been successfully marketed in the past few years and there is a promising standpoint for many more to come in the near future.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1567201816666190702153612","type":"journal-article","created":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T10:45:26Z","timestamp":1562150726000},"page":"609-617","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Carbohydrates in Vaccine Development"],"prefix":"10.2174","volume":"16","author":[{"given":"Salwa","family":"Aljohani","sequence":"first","affiliation":[{"name":"The University of Queensland, School of Chemistry and Molecular Biosciences, Cooper Road, St. Lucia QLD 4072, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waleed M.","family":"Hussein","sequence":"additional","affiliation":[{"name":"The University of Queensland, School of Chemistry and Molecular Biosciences, Cooper Road, St. Lucia QLD 4072, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Istvan","family":"Toth","sequence":"additional","affiliation":[{"name":"The University of Queensland, School of Chemistry and Molecular Biosciences, Cooper Road, St. Lucia QLD 4072, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavla","family":"Simerska","sequence":"additional","affiliation":[{"name":"The University of Queensland, School of Chemistry and Molecular Biosciences, Cooper Road, St. Lucia QLD 4072, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","author":"Plotkin S.A.","year":"2013","unstructured":"Plotkin S.A.; Orenstein W.A.; Offit P.A.; Vaccines 2013","journal-title":"Vaccines"},{"key":"ref=2","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/256784","author":"Reche P.A.","year":"2014","unstructured":"Reche P.A.; Fernandez-Caldas E.; Flower D.R.; Fridkis-Hareli M.; Hoshino Y.; Peptide-based immunotherapeutics and vaccines. J Immunol Res 2014","journal-title":"J Immunol Res"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.biologicals.2010.06.003","volume":"38","author":"Francis D.P.","year":"2010","unstructured":"Francis D.P.; Successes and failures: Worldwide vaccine development and application. Biologicals 2010,38(5),523-528","journal-title":"Biologicals"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.17576\/MH.2017.1202.11","volume":"12","author":"Wong L.K.S.","year":"2017","unstructured":"Wong L.K.S.; Muthupalaniappen L.; Tie S.T.; Knowledge, belief and barriers to adult influenza and pneumococcal vaccination among primary care doctors in sarawak. Med Health 2017,12,275-285","journal-title":"Med Health"},{"key":"ref=5","first-page":"241","volume":"92","author":"Vogel F.R.","year":"1998","unstructured":"Vogel F.R.; Modulation of the immune response to vaccine antigens, 92, F In: Brown and LR Haaheim, eds (Basel: Karger: Development in Biological Standardization), 1998,92,241-248","journal-title":"Modulation of the immune response to vaccine antigens, 92, F In: Brown and LR Haaheim, eds (Basel: Karger: Development in Biological Standardization),"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1073\/pnas.1816401115","volume":"116","author":"Sun X.","year":"2019","unstructured":"Sun X.; Stefanetti G.; Berti F.; Kasper D.L.; Polysaccharide structure dictates mechanism of adaptive immune response to glycoconjugate vaccines. Proc Natl Acad Sci USA 2019,116(1),193-198","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41541-019-0107-7","volume":"4","author":"Portillo S.","year":"2019","unstructured":"Portillo S.; Zepeda B.G.; Iniguez E.; Olivas J.J.; Karimi N.H.; Moreira O.C.; Marques A.F.; Michael K.; Maldonado R.A.; Almeida I.C.; A prophylactic \u03b1-Gal-based glycovaccine effectively protects against murine acute Chagas disease. NPJ Vaccines 2019,4,13","journal-title":"NPJ Vaccines"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/s41467-019-08869-9","volume":"10","author":"Harding C.M.","year":"2019","unstructured":"Harding C.M.; Nasr M.A.; Scott N.E.; Goyette-Desjardins G.; Nothaft H.; Mayer A.E.; Chavez S.M.; Huynh J.P.; Kinsella R.L.; Szymanski C.M.; Stallings C.L.; Segura M.; Feldman M.F.; A platform for glycoengineering a polyvalent pneumococcal bioconjugate vaccine using E. coli as a host. Nat Commun 2019,10(1),891","journal-title":"Nat Commun"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1099\/0022-1317-51-2-98","volume":"51","author":"Obaro S.","year":"2002","unstructured":"Obaro S.; Adegbola R.; The Pneumococcus: carriage, disease and conjugate vaccines. J Med Microbiol 2002,51(2),98-104","journal-title":"J Med Microbiol"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.18097\/pbmc20115701104","volume":"57","author":"Moisa A.A.","year":"2011","unstructured":"Moisa A.A.; Kolesanova E.F.; Synthetic Peptide Vaccines. Biomed Khim 2011,57(1),14-30","journal-title":"Biomed Khim"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/nchem.2396","volume":"7","author":"Jones L.H.","year":"2015","unstructured":"Jones L.H.; Recent advances in the molecular design of synthetic vaccines. Nat Chem 2015,7(12),952-960","journal-title":"Nat Chem"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1517\/17460441.2015.1067198","volume":"10","author":"Hu J.","year":"2015","unstructured":"Hu J.; Qiu L.; Wang X.; Zou X.; Lu M.; Yin J.; Carbohydrate-based vaccine adjuvants - discovery and development. Expert Opin Drug Discov 2015,10(10),1133-1144","journal-title":"Expert Opin Drug Discov"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.canlet.2018.10.013","volume":"440-441","author":"Xu X.","year":"2019","unstructured":"Xu X.; Jin Z.; Liu Y.; Gong H.; Sun Q.; Zhang W.; Zhao L.; Carbohydrate-based adjuvants activate tumor-specific Th1 and CD8 T-cell responses and reduce the immunosuppressive activity of MDSCs. Cancer Lett 2019,440-441,94-105","journal-title":"Cancer Lett"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1021\/jm701410p","volume":"51","author":"Simerska P.","year":"2008","unstructured":"Simerska P.; Abdel-Aal A.B.M.; Fujita Y.; Moyle P.M.; McGeary R.P.; Batzloff M.R.; Olive C.; Good M.F.; Toth I.; Development of a liposaccharide-based delivery system and its application to the design of group A Streptococcal vaccines. J Med Chem 2008,51(5),1447-1452","journal-title":"J Med Chem"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/cbic.201600639","volume":"18","author":"Fagan V.","year":"2017","unstructured":"Fagan V.; Hussein W.M.; Su M.; Giddam A.K.; Batzloff M.R.; Good M.F.; Toth I.; Simerska P.; Synthesis, characterization and immunological evaluation of self-adjuvanting group A streptococcal vaccine candidates bearing various lipidic adjuvanting moieties. ChemBioChem 2017,18(6),545-553","journal-title":"ChemBioChem"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/S0022-3476(96)70389-X","volume":"128","author":"King W.J.","year":"1996","unstructured":"King W.J.; MacDonald N.E.; Wells G.; Huang J.; Allen U.; Chan F.; Ferris W.; Diaz-Mitoma F.; Ashton F.; Total and functional antibody response to a quadrivalent meningococcal polysaccharide vaccine among children. J Pediatr 1996,128(2),196-202","journal-title":"J Pediatr"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"5764","DOI":"10.1128\/IAI.68.10.5764-5770.2000","volume":"68","author":"Bacon A.","year":"2000","unstructured":"Bacon A.; Makin J.; Sizer P.J.; Jabbal-Gill I.; Hinchcliffe M.; Illum L.; Chatfield S.; Roberts M.; Carbohydrate biopolymers enhance antibody responses to mucosally delivered vaccine antigens. Infect Immun 2000,68(10),5764-5770","journal-title":"Infect Immun"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.copbio.2004.10.001","volume":"15","author":"H\u00f6lemann A.","year":"2004","unstructured":"H\u00f6lemann A.; Seeberger P.H.; Carbohydrate diversity: synthesis of glycoconjugates and complex carbohydrates. Curr Opin Biotechnol 2004,15(6),615-622","journal-title":"Curr Opin Biotechnol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/nrd3012","volume":"9","author":"Astronomo R.D.","year":"2010","unstructured":"Astronomo R.D.; Burton D.R.; Carbohydrate vaccines: developing sweet solutions to sticky situations? Nat Rev Drug Discov 2010,9(4),308-324","journal-title":"Nat Rev Drug Discov"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0008-6215(00)83664-2","volume":"78","author":"Lindberg B.","year":"1980","unstructured":"Lindberg B.; Lindqvist B.; L\u00f6nngren J.; Powell D.A.; Structural studies of the capsular polysaccharide from Streptococcus pneumoniae type 1. Carbohydr Res 1980,78(1),111-117","journal-title":"Carbohydr Res"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/S0140-6736(87)91316-X","volume":"2","author":"Klugman K.P.","year":"1987","unstructured":"Klugman K.P.; Gilbertson I.T.; Koornhof H.J.; Robbins J.B.; Schneerson R.; Schulz D.; Cadoz M.; Armand J.; Protective activity of Vi capsular polysaccharide vaccine against typhoid fever. Lancet 1987,2(8569),1165-1169","journal-title":"Lancet"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1128\/CMR.00024-15","volume":"28","author":"Geno K.A.","year":"2015","unstructured":"Geno K.A.; Gilbert G.L.; Song J.Y.; Skovsted I.C.; Klugman K.P.; Jones C.; Konradsen H.B.; Nahm M.H.; Pneumococcal capsules and their types: Past, present, and future. Clin Microbiol Rev 2015,28(3),871-899","journal-title":"Clin Microbiol Rev"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1086\/426396","volume":"191","author":"Mawas F.","year":"2005","unstructured":"Mawas F.; Newman G.; Burns S.; Corbel M.J.; Suppression and modulation of cellular and humoral immune responses to Haemophilus influenzae type B (Hib) conjugate vaccine in hib-diphtheria-tetanus toxoids-acellular pertussis combination vaccines: a study in a rat model. J Infect Dis 2005,191(1),58-64","journal-title":"J Infect Dis"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/S0140-6736(06)69637-2","volume":"368","author":"Whitney C.G.","year":"2006","unstructured":"Whitney C.G.; Pilishvili T.; Farley M.M.; Schaffner W.; Craig A.S.; Lynfield R.; Nyquist A.C.; Gershman K.A.; Vazquez M.; Bennett N.M.; Reingold A.; Thomas A.; Glode M.P.; Zell E.R.; Jorgensen J.H.; Beall B.; Schuchat A.; Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study. Lancet 2006,368(9546),1495-1502","journal-title":"Lancet"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"5574","DOI":"10.1016\/j.vaccine.2009.07.036","volume":"27","author":"Br\u00f6ker M.","year":"2009","unstructured":"Br\u00f6ker M.; Dull P.M.; Rappuoli R.; Costantino P.; Chemistry of a new investigational quadrivalent meningococcal conjugate vaccine that is immunogenic at all ages. Vaccine 2009,27(41),5574-5580","journal-title":"Vaccine"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/1469-0691.12320","volume":"19","author":"Durando P.","year":"2013","unstructured":"Durando P.; Faust S.N.; Fletcher M.; Krizova P.; Torres A.; Welte T.; Experience with pneumococcal polysaccharide conjugate vaccine (conjugated to CRM197 carrier protein) in children and adults. Clin Microbiol Infect 2013,19(Suppl. 1),1-9","journal-title":"Clin Microbiol Infect"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00281-014-0461-5","volume":"37","author":"Fradin C.","year":"2015","unstructured":"Fradin C.; Bernardes E.S.; Jouault T.; Candida albicans phospholipomannan: a sweet spot for controlling host response\/inflammation. Semin Immunopathol 2015,37(2),123-130","journal-title":"Semin Immunopathol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.4161\/hv.27985","volume":"10","author":"Maue A.C.","year":"2014","unstructured":"Maue A.C.; Poly F.; Guerry P.; A capsule conjugate vaccine approach to prevent diarrheal disease caused by Campylobacter jejuni. Hum Vaccin Immunother 2014,10(6),1499-1504","journal-title":"Hum Vaccin Immunother"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"6038","DOI":"10.1016\/j.bmcl.2013.09.042","volume":"23","author":"Auzanneau F-I.","year":"2013","unstructured":"Auzanneau F-I.; Borrelli S.; Pinto B.M.; Synthesis and immunological activity of an oligosaccharide-conjugate as a vaccine candidate against Group A Streptococcus. Bioorg Med Chem Lett 2013,23(22),6038-6042","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1046\/j.1469-0691.2003.00530.x","volume":"9","author":"Ada G.","year":"2003","unstructured":"Ada G.; Isaacs D.; Carbohydrate-protein conjugate vaccines. Clin Microbiol Infect 2003,9(2),79-85","journal-title":"Clin Microbiol Infect"},{"key":"ref=31","doi-asserted-by":"publisher","DOI":"10.1002\/9780470473283.ch2","author":"Zou W.","year":"2008","unstructured":"Zou W.; Jennings H.J.; Preparation of glycoconjugate vaccines 2008","journal-title":"Preparation of glycoconjugate vaccines"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1002\/bip.20992","volume":"90","author":"Simerska P.","year":"2008","unstructured":"Simerska P.; Abdel-Aal A.B.M.; Fujita Y.; Batzloff M.R.; Good M.F.; Toth I.; Synthesis and in vivo studies of carbohydrate-based vaccines against group A streptococcus. Biopolymers 2008,90(5),611-616","journal-title":"Biopolymers"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"4292","DOI":"10.1200\/JCO.2003.04.112","volume":"21","author":"Slovin S.F.","year":"2003","unstructured":"Slovin S.F.; Ragupathi G.; Musselli C.; Olkiewicz K.; Verbel D.; Kuduk S.D.; Schwarz J.B.; Sames D.; Danishefsky S.; Livingston P.O.; Scher H.I.; Fully synthetic carbohydrate-based vaccines in biochemically relapsed prostate cancer: clinical trial results with alpha-N-acetylgalactosamine-O-serine\/threonine conjugate vaccine. J Clin Oncol 2003,21(23),4292-4298","journal-title":"J Clin Oncol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"7112","DOI":"10.1039\/C5SC01402F","volume":"6","author":"Zhou Z.","year":"2015","unstructured":"Zhou Z.; Liao G.; Mandal S.S.; Suryawanshi S.; Guo Z.; A fully synthetic self-adjuvanting globo H-Based vaccine elicited strong T cell-mediated antitumor immunity. Chem Sci (Camb) 2015,6(12),7112-7121","journal-title":"Chem Sci (Camb)"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.bmcl.2008.12.013","volume":"19","author":"Simerska P.","year":"2009","unstructured":"Simerska P.; Lu H.; Toth I.; Synthesis of a Streptococcus pyogenes vaccine candidate based on the M protein PL1 epitope. Bioorg Med Chem Lett 2009,19(3),821-824","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1602\/neurorx.2.1.44","volume":"2","author":"Egleton R.D.","year":"2005","unstructured":"Egleton R.D.; Davis T.P.; Development of neuropeptide drugs that cross the blood-brain barrier. NeuroRx 2005,2(1),44-53","journal-title":"NeuroRx"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1038\/sj.bjp.0701971","volume":"124","author":"Negri L.","year":"1998","unstructured":"Negri L.; Lattanzi R.; Tabacco F.; Scolaro B.; Rocchi R.; Glycodermorphins: opioid peptides with potent and prolonged analgesic activity and enhanced blood-brain barrier penetration. Br J Pharmacol 1998,124(7),1516-1522","journal-title":"Br J Pharmacol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"5859","DOI":"10.1021\/jm300418d","volume":"55","author":"Varamini P.","year":"2012","unstructured":"Varamini P.; Mansfeld F.M.; Blanchfield J.T.; Wyse B.D.; Smith M.T.; Toth I.; Synthesis and biological evaluation of an orally active glycosylated endomorphin-1. J Med Chem 2012,55(12),5859-5867","journal-title":"J Med Chem"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1021\/js970269p","volume":"87","author":"Nomoto M.","year":"1998","unstructured":"Nomoto M.; Yamada K.; Haga M.; Hayashi M.; Improvement of intestinal absorption of peptide drugs by glycosylation: transport of tetrapeptide by the sodium ion-dependent D-glucose transporter. J Pharm Sci 1998,87(3),326-332","journal-title":"J Pharm Sci"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1248\/bpb.22.1094","volume":"22","author":"Susaki H.","year":"1999","unstructured":"Susaki H.; Suzuki K.; Yamada H.; Okuno S.; Watanabe H.K.; Renal targeting of arginine-vasopressin by modification with carbohydrates at the tyrosine side chain. Biol Pharm Bull 1999,22(10),1094-1098","journal-title":"Biol Pharm Bull"},{"key":"ref=41","first-page":"888","volume":"288","author":"Suzuki K.","year":"1999","unstructured":"Suzuki K.; Susaki H.; Okuno S.; Yamada H.; Watanabe H.K.; Sugiyama Y.; Specific renal delivery of sugar-modified low-molecular-weight peptides. J Pharmacol Exp Ther 1999,288(2),888-897","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1745-7580-5-4","volume":"5","author":"Szab\u00f3 T.G.","year":"2009","unstructured":"Szab\u00f3 T.G.; Palotai R.; Antal P.; Tokatly I.; T\u00f3thfalusi L.; Lund O.; Nagy G.; Falus A.; Buz\u00e1s E.I.; Critical role of glycosylation in determining the length and structure of T cell epitopes. Immunome Res 2009,5,4","journal-title":"Immunome Res"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1189\/jlb.0512231","volume":"92","author":"Martinez-Pomares L.","year":"2012","unstructured":"Martinez-Pomares L.; The mannose receptor. J Leukoc Biol 2012,92(6),1177-1186","journal-title":"J Leukoc Biol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0040-4020(00)01087-5","volume":"57","author":"Kragol G.","year":"2001","unstructured":"Kragol G.; Otvos L.; Orthogonal solid-phase synthesis of tetramannosylated peptide constructs carrying three independent branched epitopes. Tetrahedron 2001,57,957-966","journal-title":"Tetrahedron"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/bip.20847","volume":"90","author":"Liu M.","year":"2008","unstructured":"Liu M.; Borgert A.; Barany G.; Live D.; Conformational consequences of protein glycosylation: preparation of O-mannosyl serine and threonine building blocks, and their incorporation into glycopeptide sequences derived from alpha-dystroglycan. Biopolymers 2008,90(3),358-368","journal-title":"Biopolymers"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/j.1567-1364.2006.00071.x","volume":"6","author":"Levitz S.M.","year":"2006","unstructured":"Levitz S.M.; Specht C.A.; The molecular basis for the immunogenicity of Cryptococcus neoformans mannoproteins. FEMS Yeast Res 2006,6(4),513-524","journal-title":"FEMS Yeast Res"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.it.2004.12.001","volume":"26","author":"Taylor P.R.","year":"2005","unstructured":"Taylor P.R.; Gordon S.; Martinez-Pomares L.; The mannose receptor: linking homeostasis and immunity through sugar recognition. Trends Immunol 2005,26(2),104-110","journal-title":"Trends Immunol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/j.1365-2567.2006.02384.x","volume":"118","author":"Sheng K.C.","year":"2006","unstructured":"Sheng K.C.; Pouniotis D.S.; Wright M.D.; Tang C.K.; Lazoura E.; Pietersz G.A.; Apostolopoulos V.; Mannan derivatives induce phenotypic and functional maturation of mouse dendritic cells. Immunology 2006,118(3),372-383","journal-title":"Immunology"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.2174\/0929867321666140826115552","volume":"21","author":"Sedaghat B.","year":"2014","unstructured":"Sedaghat B.; Stephenson R.; Toth I.; Targeting the mannose receptor with mannosylated subunit vaccines. Curr Med Chem 2014,21(30),3405-3418","journal-title":"Curr Med Chem"},{"key":"ref=50","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/S0021-9258(19)42828-7","volume":"249","author":"Bundle D.R.","year":"1974","unstructured":"Bundle D.R.; Smith I.C.P.; Jennings H.J.; Determination of the structure and conformation of bacterial polysaccharides by carbon 13 nuclear magnetic resonance. Studies on the group-specific antigens of Neisseria meningitidis serogroups A and X. J Biol Chem 1974,249(7),2275-2281","journal-title":"J Biol Chem"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1002\/eji.201142086","volume":"42","author":"Napoletano C.","year":"2012","unstructured":"Napoletano C.; Zizzari I.G.; Rughetti A.; Rahimi H.; Irimura T.; Clausen H.; Wandall H.H.; Belleudi F.; Bellati F.; Pierelli L.; Frati L.; Nuti M.; Targeting of macrophage galactose-type C-type lectin (MGL) induces DC signaling and activation. Eur J Immunol 2012,42(4),936-945","journal-title":"Eur J Immunol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1189\/jlb.0313130","volume":"94","author":"Vukman K.V.","year":"2013","unstructured":"Vukman K.V.; Ravid\u00e0 A.; Aldridge A.M.; O\u2019Neill S.M.; Mannose receptor and macrophage galactose-type lectin are involved in Bordetella pertussis mast cell interaction. J Leukoc Biol 2013,94(3),439-448","journal-title":"J Leukoc Biol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1039\/C4MD00143E","volume":"5","author":"Bhatia S.","year":"2014","unstructured":"Bhatia S.; Dimde M.; Haag R.; Multivalent glycoconjugates as vaccines and potential drug candidates. MedChemComm 2014,5,862-878","journal-title":"MedChemComm"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"3517","DOI":"10.1002\/chem.200400074","volume":"10","author":"Buskas T.","year":"2004","unstructured":"Buskas T.; Li Y.; Boons G.J.; The immunogenicity of the tumor-associated antigen Lewis(y) may be suppressed by a bifunctional cross-linker required for coupling to a carrier protein. Chemistry 2004,10(14),3517-3524","journal-title":"Chemistry"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"7561","DOI":"10.1016\/j.bmc.2007.09.005","volume":"15","author":"Wang Q.","year":"2007","unstructured":"Wang Q.; Zhang J.; Guo Z.; Efficient glycoengineering of GM3 on melanoma cell and monoclonal antibody-mediated selective killing of the glycoengineered cancer cell. Bioorg Med Chem 2007,15(24),7561-7567","journal-title":"Bioorg Med Chem"},{"key":"ref=56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0013677","volume":"5","author":"Coler R.N.","year":"2010","unstructured":"Coler R.N.; Baldwin S.L.; Shaverdian N.; Bertholet S.; Reed S.J.; Raman V.S.; Lu X.; DeVos J.; Hancock K.; Katz J.M.; Vedvick T.S.; Duthie M.S.; Clegg C.H.; Van Hoeven N.; Reed S.G.; A synthetic adjuvant to enhance and expand immune responses to influenza vaccines. PLoS One 2010,5(10)","journal-title":"PLoS One"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/0008-6215(88)84095-3","volume":"182","author":"Jansson P.E.","year":"1988","unstructured":"Jansson P.E.; Lindberg B.; Anderson M.; Lindquist U.; Henrichsen J.; Structural studies of the capsular polysaccharide from Streptococcus pneumoniae type 2, a reinvestigation. Carbohydr Res 1988,182(1),111-117","journal-title":"Carbohydr Res"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S1473-3099(05)70267-X","volume":"5","author":"Carapetis J.R.","year":"2005","unstructured":"Carapetis J.R.; Steer A.C.; Mulholland E.K.; Weber M.; The global burden of group A streptococcal diseases. Lancet Infect Dis 2005,5(11),685-694","journal-title":"Lancet Infect Dis"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"15368","DOI":"10.1021\/ja020983v","volume":"124","author":"Johnson M.A.","year":"2002","unstructured":"Johnson M.A.; Pinto B.M.; Saturation transfer difference 1D-TOCSY experiments to map the topography of oligosaccharides recognized by a monoclonal antibody directed against the cell-wall polysaccharide of group A streptococcus. J Am Chem Soc 2002,124(51),15368-15374","journal-title":"J Am Chem Soc"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.vaccine.2010.09.018","volume":"29","author":"Kabanova A.","year":"2010","unstructured":"Kabanova A.; Margarit I.; Berti F.; Romano M.R.; Grandi G.; Bensi G.; Chiarot E.; Proietti D.; Swennen E.; Cappelletti E.; Fontani P.; Casini D.; Adamo R.; Pinto V.; Skibinski D.; Capo S.; Buffi G.; Gallotta M.; Christ W.J.; Campbell A.S.; Pena J.; Seeberger P.H.; Rappuoli R.; Costantino P.; Evaluation of a Group A Streptococcus synthetic oligosaccharide as vaccine candidate. Vaccine 2010,29(1),104-114","journal-title":"Vaccine"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1093\/infdis\/126.5.514","volume":"126","author":"Wyle F.A.","year":"1972","unstructured":"Wyle F.A.; Artenstein M.S.; Brandt B.L.; Tramont E.C.; Kasper D.L.; Altieri P.L.; Berman S.L.; Lowenthal J.P.; Immunologic response of man to group B meningococcal polysaccharide vaccines. J Infect Dis 1972,126(5),514-521","journal-title":"J Infect Dis"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1128\/IAI.01108-08","volume":"77","author":"Weynants V.","year":"2009","unstructured":"Weynants V.; Deno\u00ebl P.; Devos N.; Janssens D.; Feron C.; Goraj K.; Momin P.; Monnom D.; Tans C.; Vandercammen A.; Wauters F.; Poolman J.T.; Genetically modified L3,7 and L2 lipooligosaccharides from Neisseria meningitidis serogroup B confer a broad cross-bactericidal response. Infect Immun 2009,77(5),2084-2093","journal-title":"Infect Immun"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S1473-3099(04)01251-4","volume":"5","author":"Snape M.D.","year":"2005","unstructured":"Snape M.D.; Pollard A.J.; Meningococcal polysaccharide-protein conjugate vaccines. Lancet Infect Dis 2005,5(1),21-30","journal-title":"Lancet Infect Dis"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1038\/nature05818","volume":"446","author":"Scanlan C.N.","year":"2007","unstructured":"Scanlan C.N.; Offer J.; Zitzmann N.; Dwek R.A.; Exploiting the defensive sugars of HIV-1 for drug and vaccine design. Nature 2007,446(7139),1038-1045","journal-title":"Nature"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1089\/088922204322749459","volume":"20","author":"Tsai C.C.","year":"2004","unstructured":"Tsai C.C.; Emau P.; Jiang Y.; Agy M.B.; Shattock R.J.; Schmidt A.; Morton W.R.; Gustafson K.R.; Boyd M.R.; Cyanovirin-N inhibits AIDS virus infections in vaginal transmission models. AIDS Res Hum Retroviruses 2004,20(1),11-18","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"7306","DOI":"10.1128\/JVI.76.14.7306-7321.2002","volume":"76","author":"Scanlan C.N.","year":"2002","unstructured":"Scanlan C.N.; Pantophlet R.; Wormald M.R.; Ollmann Saphire E.; Stanfield R.; Wilson I.A.; Katinger H.; Dwek R.A.; Rudd P.M.; Burton D.R.; The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120. J Virol 2002,76(14),7306-7321","journal-title":"J Virol"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1038\/nature05813","volume":"446","author":"Galoni\u0107 D.P.","year":"2007","unstructured":"Galoni\u0107 D.P.; Gin D.Y.; Chemical glycosylation in the synthesis of glycoconjugate antitumour vaccines. Nature 2007,446(7139),1000-1007","journal-title":"Nature"},{"key":"ref=68","doi-asserted-by":"crossref","first-page":"431","DOI":"10.4049\/jimmunol.146.2.431","volume":"146","author":"Kensil C. R.","year":"1991","unstructured":"Kensil C. R.; Patel U.; Lennick M.; Marciani D.; Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex. J Immunol (Baltimore, Md : 1950) 1991,146,431-437","journal-title":"J Immunol (Baltimore, Md : 1950)"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.cbpa.2013.10.001","volume":"17","author":"Wang L.X.","year":"2013","unstructured":"Wang L.X.; Synthetic carbohydrate antigens for HIV vaccine design. Curr Opin Chem Biol 2013,17(6),997-1005","journal-title":"Curr Opin Chem Biol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"3728","DOI":"10.1128\/JCM.05476-11","volume":"49","author":"Agrawal A.","year":"2011","unstructured":"Agrawal A.; Murphy T.F.; Haemophilus influenzae infections in the H. influenzae type B conjugate vaccine era. J Clin Microbiol 2011,49(11),3728-3732","journal-title":"J Clin Microbiol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1126\/science.1095209","volume":"305","author":"Verez-Bencomo V.","year":"2004","unstructured":"Verez-Bencomo V.; Fern\u00e1ndez-Santana V.; Hardy E.; Toledo M.E.; Rodr\u00edguez M.C.; Heynngnezz L.; Rodriguez A.; Baly A.; Herrera L.; Izquierdo M.; Villar A.; Vald\u00e9s Y.; Cosme K.; Deler M.L.; Montane M.; Garcia E.; Ramos A.; Aguilar A.; Medina E.; Tora\u00f1o G.; Sosa I.; Hernandez I.; Mart\u00ednez R.; Muzachio A.; Carmenates A.; Costa L.; Cardoso F.; Campa C.; Diaz M.; Roy R.; A synthetic conjugate polysaccharide vaccine against Haemophilus influenzae type b. Science 2004,305(5683),522-525","journal-title":"Science"}],"container-title":["Current Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/173172","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T23:15:31Z","timestamp":1694992531000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/173172\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,3]]},"references-count":71,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,10,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1567201816666190702153612","relation":{},"ISSN":["1567-2018"],"issn-type":[{"type":"print","value":"1567-2018"}],"subject":[],"published":{"date-parts":[[2019,10,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-12-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-03-25","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}